Skip to Main Content

Paper Details

Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
1
2023
ATP, Entinostat, HDACi, MB, MB cells, MYC, MYC-amplified medulloblastoma (MB) cells, MYC-amplified medulloblastoma cells, MYC-amplified tumor cells, MYC-driven, MYC-driven MB cells, PLK1, PLK1i, class I HDACi, class I histone deacetylase, entinostat, medulloblastoma (, mice, patient, volasertib
Author NameAffiliation
Venu ThatikondaHopp Children's Cancer Center Heidelberg (KiTZ)
Venu ThatikondaGerman Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Venu Thatikonda
Flavia BernardiInstitut Curie, PSL Research University, CNRS UMR, INSERM
Flavia BernardiUniversite Paris Sud, Universite Paris-Saclay, CNRS-UMR 7 INSERM U1021
Daniel PicardHematology and Clinical Immunology, University Hospital Dusseldorf
Daniel PicardGerman Cancer Research Center (DKFZ)
Daniel Picard
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Cornelis M van TilburgHopp Children's Cancer Center Heidelberg (KiTZ)
Cornelis M van TilburgKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Cornelis M van TilburgClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
David CapperCharite - Universitatsmedizin Berlin
David Capper
David CapperCharite - Universitatsmedizin Berlin
David Capper
Marcel KoolHopp Children's Cancer Center Heidelberg (KiTZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolGerman Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Marcel KoolHopp Children's Cancer Center Heidelberg (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marc RemkeHematology and Clinical Immunology, University Hospital Dusseldorf
Marc RemkeGerman Cancer Research Center (DKFZ)
Marc Remke
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Stefan M PfisterKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Martine F RousselSt. Jude Children's Research Hospital
Olivier AyraultInstitut Curie, PSL Research University, CNRS UMR, INSERM
Olivier AyraultUniversite Paris Sud, Universite Paris-Saclay, CNRS-UMR 7 INSERM U1021
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Olaf WittKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Research (DKTK)
Till MildeKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ)
  • 1 - 47

Datasets